CYTOMEGALOVIRUS CELL MEDIATED IMMUNITY

Clinical trials for CYTOMEGALOVIRUS CELL MEDIATED IMMUNITY explained in plain language.

Never miss a new study

Get alerted when new CYTOMEGALOVIRUS CELL MEDIATED IMMUNITY trials appear

Sign up with your email to follow new studies for CYTOMEGALOVIRUS CELL MEDIATED IMMUNITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Personalized drug break could beat daily pills for transplant patients

Disease control Recruiting now

This study is testing if stopping a CMV prevention drug (letermovir) based on a patient's own immune response works better than taking the drug every day for 200 days after a stem cell transplant. It aims to find the safest and most effective way to prevent serious CMV infections…

Matched conditions: CYTOMEGALOVIRUS CELL MEDIATED IMMUNITY

Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

CYTOMEGALOVIRUS CELL MEDIATED IMMUNITY

Get alerted when new CYTOMEGALOVIRUS CELL MEDIATED IMMUNITY trials appear

Personalized drug break could beat daily pills for transplant patients